Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531015

VENMAX

img img img img
No Data Available

VENMAX DRUGS AND PHARMACEUTICA Share Price Update

As of the latest trading session, VENMAX DRUGS AND PHARMACEUTICA share price is currently at ₹ 27.59, which is up by ₹ 0.13 from its previous closing. Today, the stock has fluctuated between ₹ 24.72 and ₹ 30.17. Over the past year, VENMAX DRUGS AND PHARMACEUTICA has achieved a return of -3.68 %. In the last month alone, the return has been 3.81 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VENMAX DRUGS AND PHARMACEUTICA fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    25.00

  • P/E Ratio (TTM)

    70.38

  • Beta

    0.44

  • Book Value / share

    11.53

  • Return on equity

    0.00%

  • EPS (TTM)

    0.39

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.03

info icon alternate text

VENMAX DRUGS AND PHARMACEUTICA Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 1.55
Operating Expense 1.58
Net Profit 0.03
Net Profit Margin (%) 1.93
Earnings Per Share (EPS) 0.05
EBITDA 0.04
Effective Tax Rate (%) 25.00
Particulars SEP 2025 (Values in Cr)
Revenue 1.32
Operating Expense 1.27
Net Profit 0.02
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.05
EBITDA 0.05
Effective Tax Rate (%) 40.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.21
Operating Expense 1.17
Net Profit 0.04
Net Profit Margin (%) 3.30
Earnings Per Share (EPS) 0.07
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.33
Operating Expense 0.58
Net Profit 0.78
Net Profit Margin (%) 236.36
Earnings Per Share (EPS) 1.49
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.20
Operating Expense 0.69
Net Profit -0.50
Net Profit Margin (%) -250.00
Earnings Per Share (EPS) -0.95
EBITDA -0.50
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.81
Operating Expense 1.87
Net Profit -0.01
Net Profit Margin (%) -1.23
Earnings Per Share (EPS) -0.02
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.09
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 0.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.43
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit 1.85
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.52
EBITDA 1.86
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.17
Operating Expense 0.51
Net Profit -0.16
Net Profit Margin (%) -94.11
Earnings Per Share (EPS) -0.31
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -1.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.11
EBITDA Margin 14.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share -1.24
ROE % 1.15
ROCE % 1.43
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.36
ROE % 4.10
ROCE % 3.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.79
ROE % 116.35
ROCE % 63.14
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.32
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -88.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 5.16
Total Liabilities 5.16
Total Equity 4.41
Share Outstanding 0
Price to Book Ratio -22.63
Return on Assets (%) -0.20
Return on Capital (%) -0.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.08
Total Liabilities 0.08
Total Equity -0.65
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 79.23
Return on Capital (%) -21.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.71
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 106.71
Return on Capital (%) -62.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.94
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 864.37
Return on Capital (%) -312.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 0.30
Total Liabilities 0.30
Total Equity -2.78
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -52.82
Return on Capital (%) 35.53
Particulars MAR 2025 (Values in Cr)
Net Income -0.01
Cash from Operations -2.29
Cash from Investing 0.00
Cash from Financing 4.77
Net change in Cash 2.47
Free Cash Flow -2.29
Particulars MAR 2024 (Values in Cr)
Net Income 0.08
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.22
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 1.84
Cash from Operations 1.90
Cash from Investing 0.00
Cash from Financing -1.98
Net change in Cash -0.07
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.16
Cash from Operations 0.26
Cash from Investing 0.00
Cash from Financing -0.18
Net change in Cash 0.07
Free Cash Flow 0.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.34 13.40 1.42 209.52 23.12 / 53.83
BLISS GVS PHARMA LTD 203.75 19.67 1.90 2155.45 105.05 / 205.75
CIPLA LTD 1342.45 22.81 3.29 108440.52 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 327.55 10.90 2.46 964.01 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2511.00 42.29 24.90 42537.86 1968.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.34 22.23 3.81 209.52 23.12 / 53.83
AMRUTAJAN HEALTH LTD 632.40 31.62 5.34 1828.31 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8675.85 93.82 27.14 21689.63 6501.60 / 10653.05
BLISS GVS PHARMA LTD 203.75 27.50 1.95 2155.45 105.05 / 205.75

VENMAX DRUGS AND PHARMACEUTICA shareholding pattern

Holding

84.86%
15.13%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VENMAX DRUGS AND PHARMACEUTICA Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
28.44 3.60 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 26.80
  • 26 Days 26.00
  • 10 Days 26.10
  • 50 Days 26.30
  • 12 Days 26.00
  • 100 Days 26.40
  • 20 Days 25.90
  • 200 Days 25.10
27.28 PIVOT

First Support

25.67

First Resistance

29.07

Second Support

23.88

Second Resistance

30.68

Third Support

22.27

Third Resistance

32.47

RSI

57.26

ADX

7.55

MACD

0.04

Williams % R

-30.49

Commodity Channel Index (CCI)

138.22

Date

2026-02-09

Week

2595.00

Same Day

8539.00

Month

2153.00

1 Year

0.45

3 Year

0.17

Over 1 Month

3.81%

down

Over 1 Year

-3.68%

down

Over 3 Months

-4.32%

down

Over 3 Years

0.00%

down

Over 6 Months

-5.57%

down

Over 5 Years

0.00%

down

VENMAX DRUGS AND PHARMACEUTICA Corporate Actions

Top Gainers

VENMAX DRUGS AND PHARMACEUTICA Share Price

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009.

For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc.

The Company is developing the oncology products in R&D. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

Venmax Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 27.59 as on Feb 10 2026 01:19 PM.

What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Venmax Drugs & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 25.00 as on Feb 10 2026 01:19 PM.

What is the 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 36.96 and ₹ 17.51.

What is 1 year return for Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -3.68%.

What is the P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Feb 10 2026 01:19 PM the price-to-earnings (PE) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 70.38.

What is the PB ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on Feb 10 2026 01:19 PM, the price-to-book (PB) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 11.53.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Venmax Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Venmax Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Venmax Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59